Mendus is a pharmaceutical company based in Sweden and the Netherlands that is dedicated to changing the course of cancer treatment by addressing tumor recurrence.
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Mendus AB →Already a subscriber? Sign in
Xcout Intel tracks Mendus AB continuously — this profile deepens as new filings, funding, people and hiring data arrive.